1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

✍ Scribed by Ferenci, P.; Asselah, T.; Foster, G.R.; Zeuzem, S.; Sarrazin, C.; Moreno, C.; Ouzan, D.; Maevskaya, M.; Calinas, F.; Morano, L.E.; Crespo, J.; Dufour, J.-F.; Bourliere, M.; Agarwal, K.; Forton, D.; Schuchmann, M.; Zehnter, E.; Nishiguchi, S.; Omata, M.; Stern, J.O.; Datzenko, Y.; Scherer, J.; Quinson, A.-M.

• Book ID: 122577984
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 73 KB
• Volume: 58
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(13)61415-4